[HTML][HTML] Trials with 'epigenetic'drugs: an update

A Nebbioso, V Carafa, R Benedetti, L Altucci - Molecular oncology, 2012 - Elsevier
Epigenetic inactivation of pivotal genes involved in correct cell growth is a hallmark of
human pathologies, in particular cancer. These epigenetic mechanisms, including crosstalk …

Emerging role of different DNA methyltransferases in the pathogenesis of cancer

P Liu, F Yang, L Zhang, Y Hu, B Chen… - Frontiers in …, 2022 - frontiersin.org
DNA methylation is one of the most essential epigenetic mechanisms to regulate gene
expression. DNA methyltransferases (DNMTs) play a vital role in DNA methylation in the …

Metformin alters DNA methylation genome-wide via the H19/SAHH axis

T Zhong, Y Men, L Lu, T Geng, J Zhou, A Mitsuhashi… - Oncogene, 2017 - nature.com
The molecular mechanisms underlying the antineoplastic properties of metformin, a first-line
drug for type 2 diabetes, remain elusive. Here we report that metformin induces genome …

Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming

R Mishra, S Haldar, V Placencio… - The Journal of …, 2018 - Am Soc Clin Investig
Prostate cancer is an androgen-dependent disease subject to interactions between the
tumor epithelium and its microenvironment. Here, we found that epigenetic changes in …

Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells

S Agarwal, KS Amin, S Jagadeesh, G Baishay, PG Rao… - Molecular cancer, 2013 - Springer
Background Hypermethylation of the promoter of the tumor suppressor gene RASSF1A
silences its expression and has been found to be associated with advanced grade prostatic …

Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation

AM Mahmoud, U Al-Alem, MM Ali… - The Journal of steroid …, 2015 - Elsevier
Genistein has protective effects against prostate cancer (PCa) but whether this protection
involves an estrogen receptor (ER) β dependent mechanism has yet to be elucidated. ER-β …

[HTML][HTML] The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer

R Ottman, J Levy, WE Grizzle, R Chakrabarti - Oncotarget, 2016 - ncbi.nlm.nih.gov
Abstract miR-17-92a cluster miRNAs are transcribed from a polycistronic transcription unit
C13orf25 that generates six mature miRNAs, miR-17, miR-18a, miR-19a, miR-19b, miR-20a …

Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells

I Graça, E J. Sousa, T Baptista… - Current …, 2014 - benthamdirect.com
Background: Current therapeutic strategies for advanced prostate cancer (PCa) are largely
ineffective. Because aberrant DNA methylation associated with inappropriate gene-silencing …

[HTML][HTML] Anti-neoplastic properties of hydralazine in prostate cancer

I Graça, EJ Sousa, P Costa-Pinheiro, FQ Vieira… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is a major cause of cancer-related morbidity and mortality worldwide.
Although early disease is often efficiently managed therapeutically, available options for …

Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells

GL Gravina, G Ranieri, P Muzi… - Oncology …, 2013 - spandidos-publications.com
DNA methylation might be the earliest somatic genome changes in prostate cancer that also
play an important role in the process of tumor invasion, growth and metastasis. In recent …